Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $4.0 | $4.9 | $5.6 | $4.8 | $10.0 | $7.0 | $7.3 | $8.3 | $8.9 | $9.3 | $9.7 | $9.4 | $14.7 | $14.5 | $18.8 | $18.2 | $25.0 | $24.6 | $25.7 | $232.9 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Elevance Health Inc.'s last 12-month EPS is $255.0, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Elevance Health Inc.'s EPS growth was 905.7%. The average annual EPS growth rates for Elevance Health Inc. have been 145.5% over the past three years, 68.5% over the past five years.
Over the last year, Elevance Health Inc.'s EPS growth was 905.7%, which is higher than industry growth of (0.1%). It indicates that Elevance Health Inc.'s EPS growth is Good.